Jemincare’s Wholly Owned Subsidiary Secures 6 Clinical Trial Approvals for Innovative Drugs

Jemincare’s Wholly Owned Subsidiary Secures 6 Clinical Trial Approvals for Innovative Drugs

Jemincare, a prominent Chinese pharmaceutical company, has announced significant progress in its drug development endeavors. Its wholly-owned subsidiary, Shanghai Jemincare…

Read More »